Merck's Keytruda Found To Extend Life Of Brain Cancer Patients

Please make sure your browser supports JavaScript and cookies and that you are not blocking them from loading. For more information you can review our Terms of Service and Cookie Policy.

Source :

Merck Drug Found to Extend Lives of Brain-Cancer Patients
Immune therapy scores big win against lung cancer in study
Keytruda Performs Well in Latest Lung Cancer Clinical Trials
Merck and DNAtrix Announce Phase 2 Immuno-Oncology Collaboration in Patients with Aggressive Form of Brain Cancer
Melanoma drugs extend life for some patients
Lung cancer patients live longer with immune therapy, study suggests
Keytruda May Be Effective in Helping Treat Brain Cancer
FDA Approves Expanded Indication for Merck’s KEYTRUDA® (pembrolizumab) for the Treatment of Patients with Advanced Melanoma